Novartis Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Novartis Pharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014306
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG is a developer, manufacturer and distributor of active ingredients, patent protected medicines and treatments for the healthcare industry. The company’s products include innovative prescription medicine and drugs, tablets, capsules, indacaterol inhalation powders, injections, combination tablets, and oral solutions. It also provides transdermal systems, subcutaneous injections, oral granules, soft gelatin capsules, and chewable tablets and suspensions, among others. Novartis offers services such as health education, patient assistance services, healthcare solutions, drug discoveries, and research and development services. The company provides its products for various therapeutic areas such as cardiovascular, central nervous systems, cancer, ophthalmics, organ transplantation, and respiratory disorders. Novartis is headquartered in East Hanover, New Jersey, the US.

Novartis Pharmaceuticals Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Novartis Pharmaceuticals Corp, Medical Devices Deals, 2011 to YTD 2017 9
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Novartis Pharma Acquires Immunotherapy Manufacturing Facility From Dendreon For US$43 Million 11
Partnerships 12
Cure Forward Partners with Novartis Pharma 12
Novartis Pharma Enters into Agreement with Eisai 13
Radius Health Partners with Novartis Pharma for RAD1901 14
Equity Offering 15
Altimmune Raises USD14.7 Million in Private Placement of Series B Preferred Shares 15
Asset Transactions 17
Validus Pharma And Wood Creek Capital Management Acquire Six Product Lines From Novartis Pharma 17
Acquisition 19
Novartis Pharma Acquires Selexys Pharma for up to USD665 Million 19
Novartis Pharmaceuticals Corp – Key Competitors 21
Novartis Pharmaceuticals Corp – Key Employees 22
Novartis Pharmaceuticals Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts 2
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Novartis Pharmaceuticals Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Novartis Pharmaceuticals Corp, Medical Devices Deals, 2011 to YTD 2017 9
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Novartis Pharma Acquires Immunotherapy Manufacturing Facility From Dendreon For US$43 Million 11
Cure Forward Partners with Novartis Pharma 12
Novartis Pharma Enters into Agreement with Eisai 13
Radius Health Partners with Novartis Pharma for RAD1901 14
Altimmune Raises USD14.7 Million in Private Placement of Series B Preferred Shares 15
Validus Pharma And Wood Creek Capital Management Acquire Six Product Lines From Novartis Pharma 17
Novartis Pharma Acquires Selexys Pharma for up to USD665 Million 19
Novartis Pharmaceuticals Corp, Key Competitors 21
Novartis Pharmaceuticals Corp, Key Employees 22
Novartis Pharmaceuticals Corp, Joint Venture 23

★海外企業調査レポート[Novartis Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RISE Life Science Corp:企業のM&A・事業提携・投資動向
    RISE Life Science Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RISE Life Science Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Inivata Ltd:企業の製品パイプライン分析
    Summary Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company’s product portfolio includes InVisionFirst – Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotid …
  • Manz AG (M5Z)-エネルギー分野:企業M&A・提携分析
    Summary Manz AG (Manz) is a manufacturer of high-technology equipment. It produces displays, printed circuit boards and other components for electronic devices. The company provides production equipment for lithium-ion battery cells, super capacitors, battery systems, and capacitors. Manz offers ind …
  • Tullow Oil plc:戦略・SWOT・企業財務分析
    Tullow Oil plc - Strategy, SWOT and Corporate Finance Report Summary Tullow Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Abu Dhabi Investment Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Investment Authority (ADIA) is a sovereign wealth fund owned and managed by Emirate of Abu Dhabi. It invests directly in global financial markets along with trusted partner’s selected external managers. The company’s investment portfolio includes developed equities, small cap equit …
  • Chembio Diagnostic Inc (CEMI):企業の財務・戦略的SWOT分析
    Chembio Diagnostic Inc (CEMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Harris Corp (HRS)-医療機器分野:企業M&A・提携分析
    Summary Harris Corp (Harris) is a communications and information technology company that offers communications products, services and systems, and network solutions. The company offers tactical and land mobile radio systems, IT services, clinically integrated solutions, managed services, government …
  • Wincor Nixdorf AG:企業の戦略・SWOT・財務情報
    Wincor Nixdorf AG - Strategy, SWOT and Corporate Finance Report Summary Wincor Nixdorf AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • China Digital Culture (Group) Limited (8175):企業の財務・戦略的SWOT分析
    China Digital Culture (Group) Limited (8175) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Heidelberger Druckmaschinen AG:企業の戦略・SWOT・財務情報
    Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report Summary Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Arbutus Biopharma Corp (ABUS):企業の財務・戦略的SWOT分析
    Arbutus Biopharma Corp (ABUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Lego AS:企業の戦略的SWOT分析
    Lego AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Ssr Mining Inc
    Ssr Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Ssr Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • PSE Kinsale Energy Ltd:企業の戦略的SWOT分析
    PSE Kinsale Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Group Five Ltd:企業の戦略的SWOT分析
    Group Five Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Air France Industries KLM Engineering and Maintenance:企業の戦略・SWOT・財務情報
    Air France Industries KLM Engineering and Maintenance - Strategy, SWOT and Corporate Finance Report Summary Air France Industries KLM Engineering and Maintenance - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Horizon Discovery Group Plc (HZD):製薬・医療:M&Aディール及び事業提携情報
    Summary Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers se …
  • Big River Gold Ltd (CAS):企業の財務・戦略的SWOT分析
    Summary Big River Gold Ltd (Big River Gold) is formerly known as Crusader resources Ltd is a mineral exploration company. The company explores for gold, iron ore and tin deposits. Its projects portfolio includes Borborema Gold project, Posse Iron Ore project, Tarantula Tungsten project, Juruena Gold …
  • Hotel Croatia Cavtat:企業の戦略・SWOT・財務分析
    Hotel Croatia Cavtat - Strategy, SWOT and Corporate Finance Report Summary Hotel Croatia Cavtat - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • bioMerieux SA (BIM):企業の財務・戦略的SWOT分析
    bioMerieux SA (BIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆